ANXA1 and Alzheimer disease: The increases in ANXA1 observed in AD brains suggest that upregulation of ANXA1 could represent an adaptive response of microglia during inflammatory conditions and an attempt of the system to calm down the inflammation at early stages of the disease, since ANXA1 effectively solves the phase of inflammation.